Pharmacologic management part 1: better-studied neuropathic pain diseases.
about
The diagnosis and management of neuropathic pain in daily practice in Belgium: an observational studyPrimary care incidence and treatment of four neuropathic pain conditions: a descriptive study, 2002-2005.Trigeminal neuralgia: frequency of occurrence in different nerve branches.The pharmacotherapy of chronic pain: a review.Evaluation of the efficacy and safety of pregabalin, venlafaxine, and carbamazepine in patients with painful diabetic peripheral neuropathy. A randomized, double-blind trial.Pharmacotherapy for neuropathic pain.Effectiveness of pregabalin as monotherapy or combination therapy for neuropathic pain in patients unresponsive to previous treatments in a Spanish primary care setting.Post hoc analysis of pregabalin vs. non-pregabalin treatment in patients with cancer-related neuropathic pain: better pain relief, sleep and physical health.First evidence of oncologic neuropathic pain prevalence after screening 8615 cancer patients. Results of the On study.Development and validation of a new HPLC method for the determination of gabapentinComparison of antinociceptive effect of the antiepileptic drug gabapentin to that of various dosage combinations of gabapentin with lamotrigine and topiramate in mice and rats.Headaches after acoustic neuroma surgery.Globus pharyngeus: effectiveness of treatment with proton pump inhibitors and gabapentin.Inhibition of type 1 diabetic hyperalgesia in streptozotocin-induced Wistar versus spontaneous gene-prone BB/Worchester rats: efficacy of a selective bradykinin B1 receptor antagonist.A multicentre, open-label, follow-on study to assess the long-term maintenance of effect, tolerance and safety of THC/CBD oromucosal spray in the management of neuropathic pain.A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment.Effect of topical neuromodulatory medications on oral and skin keratinocytes.
P2860
Q28218796-CFF2F207-2686-49C2-8475-80A34A2A003BQ33332025-667087BA-4B18-448A-A325-1DB8AA42198EQ35105554-CE358D77-9207-4608-B6DF-152E73CAC18AQ36411163-EC38AE18-20F5-4211-9E4F-28DAC6FAD651Q36504620-D2CC3C30-1989-40B9-AECE-1A761A5B20F7Q36739954-5E09E71B-8B4F-4997-B9D4-3B9E8F4261E8Q37115112-B5BE5B79-6FAA-488B-A97F-F424F3202748Q39260473-D10A2490-9DC6-4B26-9450-DEE62C1FE120Q39278779-B5C53573-487A-4C20-BCE4-FE461245C121Q39529538-1EBF21AB-5793-4B45-85B2-BC33B3B4E452Q42064160-4F35EFF1-47D9-4911-87D1-AF95D71DEACEQ44312223-1C0DD31A-0F09-4128-9E19-DB0340C29869Q46126117-77B4AF88-9C5F-48E4-AD25-6EEA9A3D33D4Q46686655-D9C278CF-31B7-4DF6-A191-1CD8B725D475Q48026611-9B4B16F6-8ED1-45F7-AE9E-70A74AD705FAQ48131842-752908D9-31F8-4983-9387-01371A0454A0Q53143835-18385038-249D-469B-9338-7B162F46A99D
P2860
Pharmacologic management part 1: better-studied neuropathic pain diseases.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Pharmacologic management part 1: better-studied neuropathic pain diseases.
@ast
Pharmacologic management part 1: better-studied neuropathic pain diseases.
@en
Pharmacologic management part 1: better-studied neuropathic pain diseases.
@nl
type
label
Pharmacologic management part 1: better-studied neuropathic pain diseases.
@ast
Pharmacologic management part 1: better-studied neuropathic pain diseases.
@en
Pharmacologic management part 1: better-studied neuropathic pain diseases.
@nl
prefLabel
Pharmacologic management part 1: better-studied neuropathic pain diseases.
@ast
Pharmacologic management part 1: better-studied neuropathic pain diseases.
@en
Pharmacologic management part 1: better-studied neuropathic pain diseases.
@nl
P921
P1433
P1476
Pharmacologic management part 1: better-studied neuropathic pain diseases.
@en
P2093
Jordi Serra
Misha-Miroslav Backonja
P304
P356
10.1111/J.1526-4637.2004.04020.X
P478
P577
2004-03-01T00:00:00Z